Black currant anthocyanins normalized abnormal levels of serum concentrations of endothelin-1 in patients with glaucoma

Journal of Ocular Pharmacology and Therapeutics

Volumn 29, Issue 5, 2013, Pages 480-487

  Yoshida, Kaori ^a   Ohguro, Ikuyo ^a   Ohguro, Hiroshi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ANTHOCYANIN; BLACK CURRANT EXTRACT; ENDOTHELIN 1; NITRIC OXIDE; PLACEBO;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EYE BLOOD FLOW; FEMALE; HUMAN; MALE; OPEN ANGLE GLAUCOMA; OPTIC NERVE DISEASE; PROTEIN BLOOD LEVEL; VISUAL FIELD;

ADMINISTRATION, ORAL; AGED; ANALYSIS OF VARIANCE; ANTHOCYANINS; ANTIOXIDANTS; CASE-CONTROL STUDIES; DOUBLE-BLIND METHOD; ENDOTHELIN-1; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; OPTIC NERVE DISEASES; RIBES; TREATMENT OUTCOME; VISUAL FIELDS;

EID: 84878581956     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2012.0198     Document Type: Article

References (66)

1. Shields, M.B. An overview of glaucoma. In: Shields, M.B., ed. Textbook of Glaucoma. 4th ed. Baltimore, Maryland: Williams & Wilkins; 1988; pp. 1-2.
2. Almasieh, M., Wilson, A.M., Morquette, B., Cueva Vargas, J.L., and Di Polo, A. The molecular basis of retinal ganglion cell death in glaucoma. Prog. Retin. Eye Res. 31:152-181, 2012.
3. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am. J. Ophthalmol. 126:498-505, 1998.
4. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AIGIS):7. The relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol. 130:429-440, 2000.
5. Kass, M.A., Heuer, D.K., Higginbotham, E.J., Johnson, C.A., Keltner, J.L., Miller, J.P., et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120:701-713, 2002. (Pubitemid 34620348)
6. Kitazawa, Y., Shirato, S., and Yamamoto, T. Optic disc hemorrhage in low-tension glaucoma. Ophthalmology. 93:853-857, 1986. (Pubitemid 16068361)
7. Leske, M.C., Heijl, A., Hussein, M., Bengtsson, B., Hyman, L., and Komaroff, E. Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol. 121:48-56, 2003. (Pubitemid 36401765)
8. Barry, C.J., Cooper, R.L., and Eikelboom, R.H. Optic disc hemorrhages and vascular abnormalities in a glaucoma population. Aust. N. Z. Ophthalmol. 25:137-144, 1997.
9. Hirota, A., Mishima, H.K., and Kiuchi, Y. Incidence of retinal vein occlusion at the glaucoma clinic of Hiroshima University. Ophthalmologica. 211:288-291, 1997. (Pubitemid 27356199)
10. Sato, E.A., Ohtake, Y., Shinoda, K., Mashima, Y., and Ki-mura, I. Decreased blood flow at neuroretinal rim of optic nerve head corresponds with visual field deficit in eyes with normal tension glaucoma. Graefes Arch. Clin. Exp. Ophthal-mol. 244:795-801, 2006. (Pubitemid 44103324)
11. Hafez, A.S., Bizzarro, R.L.G., and Lesk, M.R. Evaluation of optic nerve head and peripapillary retinal blood flow in glaucoma patients, ocular hypertensive, and normal subjects. Am. J. Ophthalmol. 136:1022-1031, 2003. (Pubitemid 37485768)
12. Emre, M., Orgul, S., Haufschild, T., Shaw, S.G., and Flammer, J. Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma. Br. J. Ophthalmol. 89:60-63, 2005. (Pubitemid 40040240)
13. Cellini, M., Possati, G.L., Profazio, V., Sbrocca, M., Car-amazza, N., and Caramazza, R. Color Doppler imaging and plasma levels of endothelin-1 in low-tension glaucoma. Acta Ophthalmol. Scand. 224:S11-S13, 1997.
14. Kaiser, H.J., Flammer, J., Wenk, M., and Luschur, T. En-dothelin-1 plasma levels in normal-tension glaucoma. Abnormal response to postural changes. Graefe's Arch. Clin. Exp. Ophthalmol. 233:484-488, 1995.
15. Ohguro, I., Ohguro, H., Ohkuro, H., and Nakazawa, M. Study of contribution of low level of plasma endothelin-1 concentration to pathogenesis of glaucomatous optic neuropathy. Hirosaki Med. J. 57:59-64, 2006.
16. Ohguro, I., Yamamoto, Y., Takeuchi, K., Ohguro, H., Mat-sumoto, M., Matsuhashi, H., et al. Relation between platelet aggregation rate and pathogenesis of glaucomatous optic neuropathy. J. Eye. 22:669-672, 2005.
17. Lee, J., Giordano, S., and Zhang, J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Bio-chem. J. 441:523-540, 2012.
18. Erdurmuxs, M., Yagci, R., Atixs, Ö., Karadag, R., Akbaxs, A., and Hepxsen, I.F. Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma. Curr. Eye Res. 36:713-718, 2011.
19. Majsterek, I., Malinowska, K., Stanczyk, M., Kowalski, M., Blaszczyk, J., Kurowska, A.K., et al. Evaluation of oxidative stress markers in pathogenesis of primary open-angle glaucoma. Exp. Mol. Pathol. 90:231-237, 2011.
20. Ghanem, A.A., Arafa, L.F., and El-Baz, A. Oxidative stress markers in patients with primary open-angle glaucoma. Curr. Eye Res. 35:295-301, 2010.
21. Zanon-Moreno, V., Marco-Ventura. P., Lleo-Perez, A., Pons-Vazquez, S., Garcia-Medina, J.J., Vinuesa-Silva, I., et al. Oxidative stress in primary open-angle glaucoma. J. Glaucoma. 17:263-268, 2008.
22. Gherghel, D., Griffiths, H.R., Hilton, E.J., Cunliffe, I.A., and Hosking, S.L. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol. Vis. Sci. 46:877-883, 2005. (Pubitemid 41321023)
23. Ferreira, S.M., Lerner, S.F., Brunzini, R., Evelson, P.A., and Llesuy, S.F. Antioxidant status in the aqueous humour of patients with glaucoma associated with exfoliation syndrome. Eye (Lond). 23:1691-1697, 2009.
24. Sorkhabi, R., Ghorbanihaghjo, A., Javadzadeh, A., Rashtch-izadeh, N., and Moharrery, M. Oxidative DNA damage and total antioxidant status in glaucoma patients. Mol. Vis. 17:41-46, 2011.
25. Renaud, S., and de Logeril, M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 339:1523-1526, 1992.
26. Kamazawa, Y., Kawaguchi, K., and Takimoto, H. Im-munomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Curr. Pharma. Des. 12:4271-4279, 2006. (Pubitemid 44669755)
27. Nakaishi, H., Matsumoto, H., Tominaga, S., and Hirayama, M. Effects of blackcurrant anthocyanoides intake on dark adaptation and VDT work-induced transient refractive alternation in healthy humans. Altern. Med. Rev. 5:553-562, 2000. (Pubitemid 32104066)
28. Matsumoto, H., Nakamura, Y., Tachibanaki, S., Kawamura, S., and Hirayama, M. Stimulatory effect ofcyanidine 3-glycosides on the regeneration of rhodopsin. J. Agric. Food Chem. 51:3560-3563, 2003.
29. Iida, H., Nakamura, Y., Matsumoto, H., Takeuchi, Y., Har-ano, S., Ishihara, M., et al. Effect of black-currant extract on negative lens-induced ocular growth in chicks. Ophthalmic. Res. 44:242-250, 2010.
30. Ohguro, I., Ohguro, H., and Nakazawa, M. Effects of an-thocyanins in black currant on retinal blood flow circulation of patients with normal tension glaucoma. A pilot study. Hirosaki Med. J. 59:23-32, 2007.
31. Ohguro, H., Ohguro, I., Katai, M., and Tanaka, S. Two-year randomized, placebo-controlled study of black currant an-thocyanins on visual field in glaucoma. Ophthalmologica. 228:26-35, 2012.
32. Rosenthal, R., and Fromm, M. Endothelin antagonism as an active principle for glaucoma therapy. Br. J. Pharmacol. 162:806-816, 2011.
33. Oku, H., Kida, T., Sugiyama, T., Hamada, J., Sato, B., and Ikeda, T. Possible involvement of endothelin-1 and nitric oxide in the pathogenesis of proliferative diabetic retinopa-thy. Retina. 21:647-651, 2001. (Pubitemid 34027780)
34. Stangos, A.N., Petropoulos, I.K., Pournaras, J.A., Mendrinos, E., and Pournaras, C.J. The vasodilatory effect of juxta-arteriolar microinjection of endothelin A receptor inhibitor in healthy and acute branch retinal vein occlusion minipig retinas. Invest. Ophthalmol. Vis. Sci. 51:2185-2190, 2010.
35. B receptor and NO/cGMP pathway. Exp. Eye Res. 80:313-322, 2005. (Pubitemid 40249888)
36. Archer, S. Measurement of nitric oxide in biological models. FASEB J. 7:349-360, 1993. (Pubitemid 23067785)
37. Servettaz, A., Guilpain, P., Goulvestre, C., Chéreau, C., Hercend, C., Nicco, C., et al. Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis. Ann. Rheum. Dis. 66:1202-1209, 2007. (Pubitemid 47309738)
38. Selmeci, L. Advanced oxidation protein products (AOPP): novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome? Free Radic. Res. 45:1115-1123, 2011.
39. Engin, K.N., Yemixsci, B., Yigit, U., Agaçhan, A., and Coxskun, C. Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patients. Mol. Vis. 16:1260-1271, 2010.
40. Chang, D., Sha, Q., Zhang, X., Liu, P., Rong, S., Han, T., et al. The evaluation of the oxidative stress parameters in patients with primary angle-closure glaucoma. PLoS One. 6:e27218, 2011.
41. Koracevic, D., Koracevic, G., Djordjevic, V., Andrejevic, S., and Cosic, V. Method for the measurement of antioxidant activity in human fluids. J. Clin. Pathol. 54:356-361, 2001. (Pubitemid 32458132)
42. McGhie, T.K., and Walton, M.C. The bioavailability and absorption of anthocyanins: towards a better understanding. Mol. Nutr. Food Res. 51:702-713, 2007. (Pubitemid 47083681)
43. Qin, Y., Xia, M., Ma, J., Hao, Y., Liu, J., Mou, H., et al. An-thocyanin supplementation improves serum LDL-and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. Am. J. Clin. Nutr. 90:485-492, 2009.
44. Duthie, S.J., Jenkinson, A.M., Crozier, A., Mullen, W., Pirie, L., Kyle, J., Yap, L.S., et al. The effects of cranberry juice consumption on antioxidant status and biomarkers relating to heart disease and cancer in healthy human volunteers. Eur. J. Nutr. 45:113-122, 2006. (Pubitemid 43345204)
45. Moller, P., Loft, S., Alfthan, G., and Freese, R. Oxidative DNA damage in circulating mononuclear blood cells after ingestion of black currant juice or anthocyanins-rich drink. Mutat. Res. 551:119-126, 2004. (Pubitemid 38833501)
46. Hirschberg, Y., Shackelford, A., Mascioli, E.A., Babayan, V.K., Bistrian, B.R., and Blackburn, G.L. The response to endotoxin in guinea-pigs after intravenous blackcurrant seed oil. Lipid. 25:491-496, 1990. (Pubitemid 20256786)
47. Matsumoto, H., Nakamura, Y., Iida, H., Ito, K., and Ohguro, H. Comparative assessment of distribution of black currant anthocyanins in rabbit and rat ocular tissues. Exp. Eye Res. 83:348-356, 2006. (Pubitemid 43850951)
48. Matsumoto, H., Inaba, H., Kishi, M., Tominaga, S., Hir-ayama, M., and Tsuda, T. Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J. Agric. Food Chem. 49:1546-1551, 2001. (Pubitemid 32884991)
49. Haefliger, I.O., Flammer, J., Bény, J.L., and Lü scher, T.F. Endothelium-dependent vasoactive modulation in the ophthalmic circulation. Prog. Retin. Eye Res. 20:209-225, 2001. (Pubitemid 32149927)
50. George, E.M., and Granger, J.P. Endothelin: key mediator of hypertension in preeclampsia. Am. J. Hypertens. 24:964-969, 2011.
51. MacCumber, M.W., and D'Anna, S.A. Endothelin receptorbinding subtypes in the human retina and choroid. Arch. Ophthalmol. 112:1231-1235, 1994. (Pubitemid 24360962)
52. Ripodas, A., de Juan, J.A., Roldán-Pallarés, M., Bernal, R., Moya, J., Chao, M., et al. Localization of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for en-dothelin-1 expression in astrocytes. Brain Res. 912:137-143, 2001. (Pubitemid 32800667)
53. Yamane, K. Endothelin and collagen vascular disease: a review with special reference to Raynaud's phenomenon and systemic sclerosis. Intern. Med. 33:579-582, 1994.
54. Ghanem, A.A., Elewa, A.M., and Arafa, L.F. Endothelin-1 and nitric oxide levels in patients with glaucoma. Ophthalmic. Res. 46:98-102, 2011.
55. Henry, E., Newby, D.E., Webb, D.J., Hadoke, P.W., and O'Brien CJ. Altered endothelin-1 vasoreactivity in patients with untreated normal-pressure glaucoma. Invest. Ophthal-mol. Vis. Sci. 47:2528-2532, 2006. (Pubitemid 351639837)
56. Kunimatsu, S., Mayama, C., Tomidokoro, A., and Araie, M. Plasma endothelin-1 level in Japanese normal tension glaucoma patients. Curr. Eye Res. 31:727-731, 2006. (Pubitemid 44373544)
57. Tezel, G., Kass, M.A., Kolker, A.E., Becker, B., and Wax, M.B. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J. Glaucoma. 6:83-89, 1997. (Pubitemid 27183191)
58. Nicolela, M.T., Ferrier, S.N., Morrison, C.A., Archibald, M.L., LeVatte, T.L., Wallace, K., et al. Effects of cold-induced vasospasm in glaucoma: the role of endothelin-1. Invest. Ophthalmol. Vis. Sci. 4:2565-2572, 2003. (Pubitemid 36618416)
59. Venkataraman, S.T., Flanagan, J.G., and Hudson, C. Vascular reactivity of optic nerve head and retinal blood vessels in glaucoma. Microcirculation. 17:568-581, 2010.
60. Good, T.J., and Kahook, M.Y. The role of endothelin in the pathophysiology of glaucoma. Expert. Opin. Ther. Targets. 14:647-654, 2010.
61. Gariepy, C.E., Ohuchi, T., Williams, S.C., Richardson, J.A., and Yanagisawa, M. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J. Clin. Invest. 105:925-933, 2000. (Pubitemid 30203065)
62. Burkhardt, M., Barton, M., and Shaw, S.G. Receptor-and non-receptor-mediated clearance of big-endothelin and en-dothelin-1: differential effects of acute and chronic ETA receptor blockade. J. Hypertens. 18:273-279, 2000. (Pubitemid 30142843)
63. B receptors induces BQ-123-sensitive hypertension in the mouse. Hypertension. 36:1002-1007, 2000.
64. B receptors. J. Appl. Physiol. 81:1510-1515, 1996. (Pubitemid 26349600)
65. B receptors in rats. Biochem. Biophys. Res. Commun. 199:1461-1465, 1994.
66. Shim, A.H., Kim, J.M., Choi, C.Y., Kim, C.Y., and Park, K.H. Ginko Biloba extract and bilberry anthocyanins improve visual function in patients with normal tension glaucoma. J. Med. Food. 15:818-823, 2012.